No Data
No Data
Cantor Fitzgerald Reiterates Overweight on Tango Therapeuticsto Overweight
Express News | Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tango Therapeutics Granted FDA Orphan Designation Status For "Small Molecule Inhibitor of PRMT5 (Protein Arginine Methyl Transferase 5)" Treatment Of Pancreatic Cancer
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
Tango Therapeutics Inc. (TNGX): Among the Most Promising Cancer Stocks According to Hedge Funds
Unlock the Full List